Technical Analysis for AMRX - Amneal Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 6.43 | 1.10% | 0.07 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| NR7 | Range Contraction | 1.10% | |
| Lower Bollinger Band Walk | Weakness | 1.10% | |
| Down 3 Days in a Row | Weakness | 1.10% | |
| Down 4 Days in a Row | Weakness | 1.10% | |
| Down 5 Days in a Row | Weakness | 1.10% | |
| Lower Bollinger Band Touch | Weakness | 1.10% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 7 hours ago |
| Up 1% | about 7 hours ago |
| Lower Bollinger Band Support | about 7 hours ago |
| Lower Bollinger Band Support | 3 days ago |
| 60 Minute Opening Range Breakdown | 4 days ago |
Get a Trading Assistant
- Earnings date: 08/02/2024
Amneal Pharmaceuticals, Inc. Description
Amneal Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. It operates in two segments, which include Impax Generics and Impax Specialty Pharma. The Impax Generics is focused on the development, manufacture, sale and distribution of the Company's generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are marketed under their drug names. The Impax Specialty Pharma is engaged in the promotion, sale and distribution of several branded products, including its branded pharmaceutical product, Rytary, an extended release oral capsule formulation of carbidopa-levodopa for the treatment of Parkinson's disease (PD), post-encephalitic Parkinsonism and Parkinsonism, and Zomig (zolmitriptan) products, indicated for the treatment of migraine headaches.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Health Sciences Drugs Pharmaceutical Products Parkinson's Disease Drug Products Treatment Of Parkinson's Disease Headache Migraine Generic Drug Migraine Headache Treatment Of Migraine Migraine Headaches
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.25 |
| 52 Week Low | 2.29 |
| Average Volume | 1,269,778 |
| 200-Day Moving Average | 5.41 |
| 50-Day Moving Average | 6.52 |
| 20-Day Moving Average | 6.70 |
| 10-Day Moving Average | 6.56 |
| Average True Range | 0.24 |
| RSI (14) | 41.86 |
| ADX | 20.28 |
| +DI | 16.27 |
| -DI | 21.04 |
| Chandelier Exit (Long, 3 ATRs) | 6.52 |
| Chandelier Exit (Short, 3 ATRs) | 7.02 |
| Upper Bollinger Bands | 7.11 |
| Lower Bollinger Band | 6.29 |
| Percent B (%b) | 0.17 |
| BandWidth | 12.14 |
| MACD Line | -0.04 |
| MACD Signal Line | 0.03 |
| MACD Histogram | -0.0674 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.68 | ||||
| Resistance 3 (R3) | 6.67 | 6.58 | 6.64 | ||
| Resistance 2 (R2) | 6.58 | 6.51 | 6.58 | 6.62 | |
| Resistance 1 (R1) | 6.50 | 6.47 | 6.54 | 6.51 | 6.61 |
| Pivot Point | 6.41 | 6.41 | 6.43 | 6.42 | 6.41 |
| Support 1 (S1) | 6.34 | 6.35 | 6.38 | 6.35 | 6.25 |
| Support 2 (S2) | 6.25 | 6.31 | 6.25 | 6.24 | |
| Support 3 (S3) | 6.17 | 6.25 | 6.22 | ||
| Support 4 (S4) | 6.18 |
